The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma

Objectives. Chemotherapy as first-/second-line treatment in different epidermal growth factor receptor (EGFR) mutation lung adenocarcinoma remains controversial. Methods. Consecutive patients were collected between 2009 and 2012. Patients were divided into two groups (1st-line chemotherapy: n = 56 a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Res Int
Hlavní autoři: Chung, Fu-Tsai, Ho, Ming-Yun, Fang, Yueh-Fu, Hshieh, Meng-Heng, Wang, Tsai-Yu, Kuo, Chih-Hsi, Chen, Hao-Cheng, Wang, Chun-Hwa, Lin, Shu-Min, Yu, Chih-Teng, Lin, Horng-Chyuan, Kuo, Han-Pin
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4644829/
https://ncbi.nlm.nih.gov/pubmed/26609535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/948267
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky